Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance

Cambodia's first-line artemisinin combination therapy, dihydroartemisinin-piperaquine (DHA-PPQ), is no longer sufficiently curative against multidrug-resistant Plasmodium falciparum malaria at some Thai-Cambodian border regions. We report recent (2008 to 2013) drug resistance trends in 753 isol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Chaorattanakawee, Suwanna, Saunders, David L., Sea, Darapiseth, Chanarat, Nitima, Yingyuen, Kritsanai, Sundrakes, Siratchana, Saingam, Piyaporn, Buathong, Nillawan, Sriwichai, Sabaithip, Chann, Soklyda, Se, Youry, Yom, You, Heng, Thay Kheng, Kong, Nareth, Kuntawunginn, Worachet, Tangthongchaiwiriya, Kuntida, Jacob, Christopher, Takala-Harrison, Shannon, Plowe, Christopher, Lin, Jessica T., Chuor, Char Meng, Prom, Satharath, Tyner, Stuart D., Gosi, Panita, Teja-Isavadharm, Paktiya, Lon, Chanthap, Lanteri, Charlotte A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Epidemiology and Surveillance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505231/
https://ncbi.nlm.nih.gov/pubmed/26014942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00366-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados